Claim · 2024-09-05 · publication · Stated in source · Supported

Google DeepMind's announcement of 5 September 2024 states that AlphaProteo is an AI system that designs proteins that "successfully bind to target molecules", with potential for advancing drug design and disease understanding.

One recorded claim. The claim panel gives its qualification, the source passages with their place in each source, and how it was checked.

What it connects

AlphaProteo generates novel proteins for biology and health research → states provision → AlphaProteo described as designing proteins that bind to target molecules

Where it appears

No collection page holds this claim. It is listed with its records in the explorer.

Claim and evidence

AlphaProteo generates novel proteins for biology and health researchstates provision ↓AlphaProteo described as designing proteins that bind to target molecules

Machine-checked, not reviewed by an editorStated in sourceSupported

Supporting evidence: primary · 1 source

Provision: Statement · provision ID mod-alphaproteo-statement
Date: 2024-09-05 · publication Records dated 2024 →

Scope and limitsA company statement about its own system, dated by the announcement; no independent evaluation, and no technical detail of the system or its outputs is recorded. Only the announcement's summary and policy-level passages are recorded; its descriptions of design targets and experimental results were deliberately not quoted.

The evidence 01

primary sourceSupports the claim

AlphaProteo generates novel proteins for biology and health research

Google DeepMind · 2024-09-05

Cite the original source

Cite the original document, not Selekoa. Check these details against it.

Source excerpt

“New AI system designs proteins that successfully bind to target molecules, with potential for advancing drug design, disease understanding and more.”

Location in source post standfirst

How it was read Retrieved directly from the publisher

Machine-checked · 2026-10-30

Source details and check notes

Authors: Protein Design and Wet Lab teams
Version: Retrieved for the candidate pack on 2026-10-30 (SHA-256 09f47998d506a1da29744dbce09a0dea9c44cac8415e3adaf26f2feb7acaf539). Post dated 5 September 2024, page as served on 2026-10-30. Its wording can change; earlier wording is not authenticated.
Canonical address: Open the canonical source ↗
Accessed: 2026-10-30
Language: English (en)
Attribution: Protein Design and Wet Lab teams, “AlphaProteo generates novel proteins for biology and health research”, 2024-09-05.
Reuse: No open redistribution licence asserted. Bibliographic metadata, editorial paraphrases and short attributed quotations (at most 50 words each). Recheck terms before wider redistribution.
Check notes: Candidate pack passage, AI in biology (research/ai-in-biology). The quotation (21 words) matched the text retrieved for the candidate pack on 2026-10-30. Matching ignored differences of whitespace, case, quotation marks, dashes and Unicode compatibility forms, so the source’s typography can differ. A cross-family machine check (2026-10-30, item B48) re-read the record’s sources and found full support. No human editorial review.

Status and meaning

Editorial status. Not reviewed by an editor. An exploratory record that no editor has accepted. This status does not say whether a person has read any linked passage. Each evidence record above shows how it was checked.

Relation. An exact framework edition, or another document with an exact expression, states one provision: a capability threshold or risk level and its trigger, a required safeguard or action, a decision authority (who decides, recommends, can overrule or is informed), a stated exception, or another statement of its content, such as a licence term or a prospectus statement. The passage records what the document says, not implementation, compliance or effectiveness. Provisions with the same key align across editions of one family.

Date. Date of the announcement making the statement.

Record ID aib-mod-alphaproteo-statement